← All trials
NCT06011005
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2023
- Primary completion
- Oct 24, 2023
- Completion date
- Dec 31, 2023
- First posted
- Aug 25, 2023
- Last posted
- Aug 25, 2023
- Enrollment
- 42
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mohammed Bin Rashid University of Medicine and Health SciencesLead sponsor
- Mohammed Bin Rashid University of Medicine and Health SciencesOverall official - principal investigator
- Mohammed Bin Rashid University of Medicine and Health SciencesReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.